Latest DEF 14A proxy statements

Quanterix Corporation adjourned its 2025 Annual Meeting of Stockholders to allow more time for voting on proposals to eliminate supermajority voting requirements.

Mural Oncology plc announces the publication of the Rule 15 Proposal and definitive proxy statement related to its acquisition by XOMA Royalty Corporation for cash.

Mural Oncology plc details the treatment of equity awards for its proposed acquisition by XRA 5 Corp., a subsidiary of XOMA Royalty Corporation, for a cash consideration of $2.035 to $2.24 per share.

Mural Oncology plc has commenced mailing its definitive proxy statement to shareholders regarding the acquisition by XOMA Royalty Corporation via a scheme of arrangement.

Mural Oncology plc shareholders to vote on a scheme of arrangement for acquisition by XOMA Royalty Corporation, offering $2.035 to $2.24 per share in cash.

Tesla updated its website and social media with materials related to its 2025 Annual Meeting of Shareholders, urging shareholders to review proxy statements.

Aviat Networks, Inc. has filed definitive additional proxy soliciting materials with the SEC.

Amcor PLC announces its 2025 Annual General Meeting, seeking shareholder votes on director re-elections, auditor ratification, executive compensation, and a proposed reverse stock split.

KLA Corporation announced the details for its 2025 Annual Meeting of Stockholders, including director elections, auditor ratification, and executive compensation vote.

AgriFORCE Growing Systems, Ltd. is undergoing a major strategic pivot, rebranding to Avax One and shifting its focus from AgriTech to a digital asset treasury strategy centered on the Avalanche blockchain.

Workhorse Group and Motiv Power Systems highlight their pending merger by announcing the deployment of four electric school buses in New Jersey, with 25 more planned.

Eaton Vance Senior Income Trust filed a supplement to its proxy statement to correct inadvertent errors regarding outstanding shares and the annual meeting date.

IX Acquisition Corp. is seeking shareholder approval for a fourth extension to complete a business combination, pushing the deadline to October 2026, following its delisting from Nasdaq.

Aviat Networks, Inc. announced its 2025 Annual Meeting of Stockholders, featuring director elections, auditor ratification, executive compensation vote, and a proposal to expand its incentive plan.

RYVYL Inc. will hold its 2025 Annual Meeting to vote on a reverse stock split, an increase in authorized shares, director elections, and auditor ratification, addressing Nasdaq listing compliance.

Sharps Technology, Inc. calls a Special Meeting to approve significant warrant issuances and a new director, signaling substantial dilution for existing shareholders.

NovaBay Pharmaceuticals announces a strategic pivot with a new $6.0 million investment from David E. Lazar, leading to significant shareholder dilution and a planned reverse stock split.

Exicure, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on November 6, 2025, to vote on director elections, auditor ratification, and executive compensation.

KLA Corporation announced robust financial performance for fiscal year 2025, with significant increases in revenue, net income, and EPS, alongside proactive ESG initiatives and board enhancements.

Amcor PLC's proxy statement details a proposed 1-for-5 reverse stock split, reports strong fiscal year 2025 performance including volume growth and successful Berry Global merger integration, and outlines executive compensation and board re-elections.

Quantum Corporation has entered into a definitive agreement to restructure its outstanding term debt, exchanging approximately $52 million for senior secured convertible notes and eliminating existing financial covenants.

Independent proxy firm ISS recommends shareholders vote for Cushman & Wakefield's proposed redomiciliation to Bermuda, citing expected annual savings of US$3 million and enhanced corporate governance.

Profusa, Inc. is calling a Special Meeting of Stockholders to approve a significant convertible note financing and an increase in authorized common stock to support future growth and capital needs.

ATAI Life Sciences and Beckley Psytech announced positive Phase 2a clinical trial results for BPL-003, showing improved and sustained antidepressant effects with a two-dose regimen in treatment-resistant depression patients.

Ares Acquisition Corporation II and Kodiak Robotics, Inc. announced over $275 million in financing to support their proposed business combination, despite high shareholder redemptions and a postponed Extraordinary General Meeting.

The Marygold Companies, Inc. announced its 2025 Annual Meeting of Stockholders to be held on November 7, 2025, focusing on director elections and auditor ratification.

Big 5 Sporting Goods Corporation has rescheduled its special stockholder meeting to September 26, 2025, to vote on the proposed merger with Worldwide Sports Group Holdings LLC, while also addressing an unsolicited, deficient acquisition proposal from Party A.

BlackRock funds will hold special shareholder meetings on October 15, 2025, to vote on proposed reorganizations and mergers.

BlackRock MuniYield Michigan Quality Fund and other funds will hold a special shareholder meeting on October 15, 2025, to vote on proposed reorganizations/mergers.

Golden Matrix Group, Inc. announces its 2025 Annual Meeting of Stockholders to vote on director appointments, executive compensation, and auditor selection.